Recruiting

Mobile App Research

Sponsor:

M.D. Anderson Cancer Center

Code:

NCT04611087

Conditions

Obesity-Related Malignant Neoplasm

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Interventions

Discussion

Interview

Survey Administration

Study Details

Brief summary:

This study investigates how individuals feel about a dietary mobile application. Information collected from focus groups and interviews may help doctors and mobile application developers to determine preferences and participant feedback about the appeal and usefulness of a mobile application.

Conditions

Obesity-Related Malignant Neoplasm

Study ID

NCT04611087

Start date

Jul 3, 2018

Status verified date

Aug, 2026

Completion date

Apr 30, 2027

Anticipated

Primary completion date

Apr 30, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Pasadena Independent School District (ISD) employees who have completed the 6-month Vibrant Lives weight loss program or adults who have completed a weight loss program within the last 12 months

Study Design

Enrollment

39 participants

Anticipated

Interventions and Outcome Measures

Arms

Observational (focus group, interview)

PHASE I: Participants attend 4 sessions of focus groups.

PHASE II: Participants attend virtual Zoom interviews or one-on-one interviews.

Interventions

Discussion

Attend focus groups

Interview

Attend interviews

Survey Administration

Ancillary studies

Primary outcome measure

  • Preferences of food and beverage self-monitoring methodology and respective feedback messages [ Time Frame: Up to 3 years ]

Central Contacts and Locations

Central contacts

Locations

M D Anderson Cancer Center

Recruiting

Houston, Texas, United States, 77030

Contacts

Karen M. Basen-Engquist

713-745-3123

Principal Investigator:

Karen M. Basen-Engquist

More Information

Sponsor

M.D. Anderson Cancer Center

Last update posted

Aug 11, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-08-11.